Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer Farhat Nasim22 April 2019 9:30 AM ISTNew Delhi: Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (USFDA) has approved...
Biocon launches colon cancer drug in India, priced Rs 24,000 Ruby Khatun Khatun24 Nov 2017 10:01 AM ISTBengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 10:07 AM ISTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Bristols drug cocktail cuts kidney cancer death risk 37 percent Ruby Khatun Khatun14 Sept 2017 9:25 AM ISTMADRID: A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients,...
Bristol-Myers stops kidney cancer drug test after early success Ruby Khatun Khatun11 Sept 2017 10:48 AM ISTBristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end...
